Which approach reduces bias when discussing treatment costs with patients?

• A. Assume higher cost reduces adherence.
• B. Present options neutrally, consider financial barriers, and avoid assumptions about adherence.
• C. Always recommend the most expensive option.
• D. Delay cost discussion until after treatment.

Answer: (B)

Reducing bias in cost conversations comes from presenting options neutrally and acknowledging financial barriers. When you lay out all viable treatment choices without pushing one because of price, you invite the patient to weigh what matters most to them—outcomes, values, and budget—while staying aware of how cost might impact access. This neutral approach supports informed, shared decision-making and shows respect for the patient’s autonomy.

If you assume that a higher-cost option will automatically reduce adherence, you’re applying a stereotype rather than considering the individual’s situation. That kind of assumption can skew information, steer patients toward or away from certain options based on price, and erode trust. Recommending the most expensive option every time likewise introduces financial bias and can create inequities in care, making it harder for patients to engage meaningfully in decisions. Delaying cost discussions until after a treatment plan is proposed undermines transparency and may pressure patients into plans they cannot afford.

By presenting options clearly, asking about financial barriers, and avoiding assumptions about adherence, you create a fair, patient-centered dialogue that supports equitable access and better-aligned treatment choices.